IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acuta Capital Partners, LLC

Q1 2017 Holdings

Filed 2017-05-15 | 67 holdings | $52.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)CallCOM004225108$7.2K210,0000.0%
Nabriva Therapeutics AGSPONSORED ADR62957M104$8.1K677,7100.0%
Webmd Health CorpCallCOM94770V102$10.0K190,0000.0%
Neuroderm LTDORD SHSM74231107$11.9K450,0000.0%
Edge Therapeutics IncCOM279870109$12.3K1,351,5160.0%
Iridex Corp(IRIX)COM462684101$20.1K1,691,8650.0%
Lion Biotechnologies IncCOM53619R102$25.4K3,415,0440.0%
Assembly Biosciences IncCOM045396108$28.0K1,100,0000.1%
Veracyte Inc(VCYT)COM92337F107$28.3K3,083,5590.1%
Ishares TR(IWM)PutRUSSELL 2000 ETF464287655$39.9K290,0000.1%
Spdr Series Trust(XBI)PutS&P BIOTECH78464A870$50.6K730,0000.1%
Aehr Test Systems(AEHR)COM00760J108$587.0K122,0001.1%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$2.9M400,0005.6%
Aclaris Therapeutics Inc(ACRS)COM00461U105$6.0M200,00011.3%
Biocryst Pharmaceuticals(BCRX)COM09058V103$7.7M920,31014.7%
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$15.4M550,00029.2%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$19.7M572,75637.4%
PreviousPage 2 of 2